在接受皮下埃诺沙巴林治疗的患者中,腹腔内血瘤和可识别的危险因素
Stephanie Lager1, Gautam Balakrishnan1, Riley Eiberger1
1Mosaic Life Care, Saint Joseph, MO, United States of America.
PloS one
|April 16, 2024
概括
低分子量肝素,像恩沙巴林一样,可以引起腹部血液瘤. 患有功能障碍的老年患者患上这些严重出血的风险更高.
科学领域:
- 医学研究 医学研究
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 低分子量肝素 (LMWH) 是一种广泛使用的抗凝剂.
- 虽然有效,但LMWH存在风险,包括自发腹部出血.
- 现有的关于LMWH相关腹部血瘤的文献主要基于病例报告.
研究的目的:
- 为了确定使用enoxaparin的患者腹部血瘤的发病率.
- 为了确定与素诱导的腹部血瘤相关的危险因素.
- 评估埃诺沙巴林在社区医院环境中的腹部出血中的作用.
主要方法:
- 追溯分析44名在8个月内接受埃诺沙巴林治疗的患者.
- 25名患者因外部原因或时间问题而被排除在外.
- 在19名符合条件的患者中评估风险因素,包括年龄,性别,功能 (肌素清除率) 和体重.
主要成果:
- 超过一半的临床显著出血患者是老年人 (年龄>65岁).
- 功能受损 (肌素清除率≤60毫升/分钟) 是一个常见的发现.
- 该研究确定了特定的风险增加的患者个人资料.
结论:
- 患有肌素清除率<60毫升/分钟的女性患者有风险.
- 肥胖 (BMI>30 kg/m2) 与功能受损相结合会增加风险.
- 埃诺沙巴林治疗剂量在风险人群中需要仔细考虑.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
689
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
689
Disorders of Hemostasis
881
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
881
Esophageal Varices-I: Introduction
124
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
124
Extrinsic and Intrinsic Pathways of Hemostasis
7.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.4K
Esophageal Varices-II: Clinical Features and Management
60
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
60


